Director of Research at INSERM Unité 1026 BioTis, Université de Bordeaux, Dr L’Heureux’s career began as a Postdoctoral Fellow of the American Heart Association at the Department of Bioengineering. From there he co-founded and was the Chief Scientific Officer at Cytograft Tissue Engineering for 15 years, leading to the first implantation of tissue engineered blood vessels in a human. Dr L’Heureux’s expertise includes tissue engineering with a focus on vascular applications, human cell culture and extracellular matrix. His entrepreneurship has led him into advisory and consulting roles with companies including Xeltis. He is affiliated with eight scientific societies including Tissue Engineering Regenerative Medicine International Society (TERMIS), International Society for Applied Cardiovascular Biology (ISACB), the American Heart Association (AHA) and the Cardio-Thoracic and Vascular Surgery AHA Scientific Council, among others.